Zach Scheiner
Partner·RA Capital Management
Zach Scheiner is a Partner on RA Capital's Investment Team, where he works on public and private investments. He serves as a board director for Sparrow Pharmaceuticals, LENZ Therapeutics, Nkarta Therapeutics, SpyGlass Pharma, and Sydnexis, with additional public bios linking him to Exo Imaging. Before RA Capital, he worked as a Science Officer at the California Institute for Regenerative Medicine.
See the rest of Zach Scheiner's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.